medigraphic.com
Organo Oficial de la Sociedad Mexicana de Urología

2026, Number 2

<< Back Next >>

Rev Mex Urol 2026; 86 (2)

Surgical management of adrenal incidentalomas in a secondary care hospital: mexican institutional experience

Romero-Uribe JL, Camacho-Castro AJ, Valenzuela-Espinoza JÁ, Bravo-Santoyo N

Language: Spanish
References: 21
Page: 1-11
PDF size: 890.16 Kb.


ABSTRACT

Objective: to analyze the clinical, imaging and surgical characteristics of patients with adrenal incidentalomas undergoing exclusively surgical treatment in a secondary level hospital.
Design: retrospective, observational, and descriptive study including patients diagnosed with adrenal incidentalomas who underwent surgical treatment.
Results: a total of 18 cases were identified, with a mean patient age of 49.8 years (range 29–76). Female predominance was observed (61.1 %), with left-sided lesions in 72.2 % of cases. Laparoscopic adrenalectomy was performed in 66.7 % of patients, mainly for benign tumors (75 %), whereas open surgery was reserved for lesions ≥ 6 cm or with clinical or radiologic suspicion of malignancy. The most frequent histopathological diagnosis was adrenal adenoma (38.9 %), followed by adrenocortical carcinoma (22.2 %) and pheochromocytoma (11.1 %).
Limitations: small sample size and retrospective design; however, the findings are consistent with previously published international series.
Originality: this study represents the first institutional series of adrenal incidentalomas reported from a secondary-level hospital in northwest Mexico, providing local evidence on their clinical and surgical management.
Conclusion: although adrenal incidentalomas are relatively uncommon findings, accurate preoperative functional and imaging assessment combined with an appropriate surgical approach favoring minimally invasive techniques when feasible significantly improves clinical and surgical outcomes.


REFERENCES

  1. Fassnacht M, Tsagarakis S, Terzolo M,Tabarin A, Sahdev A, Newell-Price J, et al.European Society of Endocrinology clinicalpractice guidelines on the management ofadrenal incidentalomas, in collaborationwith the European Network for the Studyof Adrenal Tumors. European Journal ofEndocrinology. 2023;189(1): G1–G42. https://doi.org/10.1093/ejendo/lvad066.

  2. Zeiger MA, Thompson GB, Duh QY, HamrahianAH, Angelos P, Elaraj D, et al. AmericanAssociation of Clinical Endocrinologists andAmerican Association of Endocrine SurgeonsMedical Guidelines for the Management ofAdrenal Incidentalomas: executive summary ofrecommendations. Endocrine Practice: OfficialJournal of the American College of Endocrinologyand the American Association of ClinicalEndocrinologists. 2009;15(5): 450–453. https://doi.org/10.4158/EP.15.5.450.

  3. Cawood TJ, Hunt PJ, O’Shea D, Cole D,Soule S. Recommended evaluation of adrenalincidentalomas is costly, has high false-positiverates and confers a risk of fatal cancer that issimilar to the risk of the adrenal lesion becomingmalignant; time for a rethink? European Journalof Endocrinology. 2009;161(4): 513–527.https://doi.org/10.1530/EJE-09-0234.

  4. Young WF. Clinical practice. The incidentallydiscovered adrenal mass. The New EnglandJournal of Medicine. 2007;356(6): 601–610.https://doi.org/10.1056/NEJMcp065470.

  5. Bovio S, Cataldi A, Reimondo G, Sperone P,Novello S, Berruti A, et al. Prevalence of adrenalincidentaloma in a contemporary computerizedtomography series. Journal of EndocrinologicalInvestigation. 2006;29(4): 298–302. https://doi.org/10.1007/BF03344099.

  6. Kim BY, Chun AR, Kim KJ, Jung CH, KangSK, Mok JO, et al. Clinical Characteristics andMetabolic Features of Patients with AdrenalIncidentalomas with or without SubclinicalCushing’s Syndrome. Endocrinology andMetabolism. 2014;29(4): 457–463. https://doi.org/10.3803/EnM.2014.29.4.457.

  7. Mishra I, Vivek MV, Baliarsinha AK. FRI174Spectrum Of Presentation Of AdrenalIncidentalomas: Is The Distribution Changing?Experience From A Tertiary Care Centre OfEastern India. Journal of the Endocrine Society.2023;7(Suppl 1): bvad114.169. https://doi.org/10.1210/jendso/bvad114.169.

  8. Cho YY, Suh S, Joung JY, Jeong H, Je D, YooH, et al. Clinical characteristics and follow-upof Korean patients with adrenal incidentalomas.The Korean Journal of Internal Medicine.2013;28(5): 557–564. https://doi.org/10.3904/kjim.2013.28.5.557.

  9. Mantero F, Terzolo M, Arnaldi G, Osella G,Masini AM, Alı̀ A, et al. A Survey on AdrenalIncidentaloma in Italy1. The Journal of ClinicalEndocrinology & Metabolism. 2000;85(2): 637–644. https://doi.org/10.1210/jcem.85.2.6372.

  10. Mansmann G, Lau J, Balk E, Rothberg M, MiyachiY, Bornstein SR. The clinically inapparent adrenalmass: update in diagnosis and management.Endocrine Reviews. 2004;25(2): 309–340. https://doi.org/10.1210/er.2002-0031.

  11. Fassnacht M, Arlt W, Bancos I, Dralle H,Newell-Price J, Sahdev A, et al. Managementof adrenal incidentalomas: European Societyof Endocrinology Clinical Practice Guidelinein collaboration with the European Networkfor the Study of Adrenal Tumors. EuropeanJournal of Endocrinology. 2016;175(2): G1–G34.https://doi.org/10.1530/EJE-16-0467.

  12. Boland GWL, Blake MA, Hahn PF, Mayo-SmithWW. Incidental adrenal lesions: principles,techniques, and algorithms for imagingcharacterization. Radiology. 2008;249(3):756–775. https://doi.org/10.1148/radiol.2493070976.

  13. Pineda-Murillo J, Vergara-Vizuet J, Hernández-León O, Torres-Aguilar J, Viveros-ContrerasC, Marin-Guizar DM, et al. Tratamientolaparoscópico transperitoneal de mielolipomasuprarrenal. Revista mexicana de urología.2017;77(3): 213–218.

  14. Morelli V, Palmieri S. Adrenal incidentaloma:differential diagnosis and managementstrategies. Edizioni Minerva Medica. 2019;44(1):4–18. https://doi.org/10.23736/S0391-1977.18.02868-7

  15. Yoneda K, Shiba E, Watanabe T, Akazawa K,Shimazu K, Takamura Y, et al. Laparoscopicadrenalectomy: lateral transabdominalapproach vs posterior retroperitoneal approach.Biomedicine & Pharmacotherapy. 2000;54:215s–219s. https://doi.org/10.1016/S0753-3322(00)80048-7.

  16. Porpiglia F, Fiori C, Bovio S, Destefanis P, AlìA, Terrone C, et al. Bilateral adrenalectomy forCushing’s syndrome: a comparison betweenlaparoscopy and open surgery. Journal ofEndocrinological Investigation. 2004;27(7): 654–658. https://doi.org/10.1007/BF03347498.

  17. Gac E P, Cabané T P, Jans B J, Marambio G A,Díaz B M, Araya Q V, et al. Manejo quirúrgicodel incidentaloma suprarrenal. Revista chilenade cirugía. 2012;64(1): 25–31. https://doi.org/10.4067/S0718-40262012000100005.

  18. Bansal VK, Asuri K, Singh D, Agarwal K,Dixit R, Prakash O, et al. Outcomes followinglaparoscopic adrenalectomy: Experience ofmore than two decades at a tertiary care centre.Journal of Minimal Access Surgery. 2025;21(1):46. https://doi.org/10.4103/jmas.jmas_8_24.

  19. Lee JM, Kim MK, Ko SH, Koh JM, Kim BY, KimSW, et al. Clinical Guidelines for the Managementof Adrenal Incidentaloma. Endocrinology andMetabolism. 2017;32(2): 200–218. https://doi.org/10.3803/EnM.2017.32.2.200.

  20. Koren C, Ferraris F, Lapenna L, CardinaliC, Labrador J, Villaronga A, et al. Manejoquirúrgico de los tumores suprarrenales.Nuestra experiencia. Revista Argentina deUrología. 2012;77(2): 136–141.

  21. Ramírez-Beltrán AA, Rosas-Nava JE, Franco-Morales A, Medrano-Urtecho HM, González-Cuenca E, Corona-Montes VE, et al. Adrenal cyst:our experience in its laparoscopic management.Cirugia Y Cirujanos. 2021;89(2): 252–257.https://doi.org/10.24875/CIRU.20000265.




2020     |     www.medigraphic.com